Why Do Some People Keep Getting UTIs?

Urinary tract infections (UTIs) are among the most common bacterial infections, and for many women, they are not a one-time event. While a single UTI is uncomfortable enough, dealing with repeated infections can be exhausting, disruptive, and deeply frustrating. Understanding why recurrent UTIs happen is the first step toward breaking the cycle.

A UTI is classified as recurrent when a person experiences two or more infections within six months, or three or more within a twelve-month period. These episodes may be caused by the same organism (relapse) or by a new pathogen (reinfection), and the distinction matters for treatment planning.

Recurrent UTIs are remarkably common. Studies estimate that approximately 1 in 3 women will have had at least one UTI by age 24, and more than 50% of women will experience a UTI in their lifetime. Among those who have a single UTI, roughly 26% will experience a recurrence within six months. This is not a rare or unusual problem -- it is one of the most frequent reasons women seek medical care.

Written by Ankitha | Medically reviewed by Dr. Mohan Pandit

Recognizing the Symptoms

UTI symptoms can range from mildly annoying to severely debilitating. Recognizing the signs early allows for prompt treatment and may prevent the infection from spreading to the kidneys. Common symptoms of a lower urinary tract infection (cystitis) include:

• Burning or stinging sensation during urination (dysuria) -- often the first and most noticeable symptom
• Increased urinary frequency -- feeling the need to urinate much more often than usual, even when the bladder is not full
• Urgency -- a sudden, strong need to urinate that is difficult to delay
• Cloudy, dark, or strong-smelling urine
• Blood in the urine (hematuria) -- urine may appear pink, red, or cola-coloured
• Pelvic pressure or discomfort -- particularly in the area above the pubic bone
• Low-grade fever or general malaise

If the infection ascends to the kidneys (pyelonephritis), more serious symptoms may develop, including high fever, chills, flank or back pain, nausea, and vomiting. Kidney infections require urgent medical attention and typically more aggressive antibiotic therapy.

What Causes Recurrent UTIs?

The Bacteria Behind UTIs

The vast majority of UTIs -- approximately 80 to 90% -- are caused by Escherichia coli (E. coli), a bacterium that normally lives in the gastrointestinal tract. When E. coli migrates from the perianal area to the urethra and bladder, it can adhere to the bladder wall lining and multiply, triggering infection. Other organisms that can cause UTIs include:

• Klebsiella pneumoniae
• Enterococcus faecalis
• Proteus mirabilis
• Staphylococcus saprophyticus (particularly common in younger, sexually active women)
• Pseudomonas aeruginosa (more common in catheter-associated or hospital-acquired UTIs)

Some strains of E. coli have evolved specialized structures called type 1 pili (fimbriae) that allow them to attach firmly to the bladder epithelium. These uropathogenic strains can invade bladder cells, forming intracellular bacterial communities that are shielded from antibiotics and the immune system. This mechanism helps explain why some infections seem to return even after successful treatment.

Reinfection vs. Relapse

Understanding the distinction between reinfection and relapse is clinically important:

• Reinfection accounts for approximately 80% of recurrent UTIs. In these cases, the original infection resolves completely, but a new infection develops -- often caused by a different bacterial strain. Reinfections typically occur more than two weeks after the prior episode has cleared.
• Relapse occurs when the same organism that caused the original UTI persists despite treatment and causes symptoms again, usually within two weeks of completing antibiotics. Relapse may indicate an inadequate treatment course, antibiotic resistance, or a structural abnormality in the urinary tract that harbours bacteria.

Risk Factors

Several anatomical, behavioural, hormonal, and medical factors contribute to recurrent UTIs:

Anatomical Factors

• Shorter urethra -- Women have a much shorter urethra than men (approximately 4 cm vs. 20 cm), which means bacteria have a shorter distance to travel to reach the bladder.
• Proximity of the urethra to the anus -- This facilitates migration of fecal bacteria to the urinary tract.
• Incomplete bladder emptying -- Residual urine provides a medium for bacterial growth. This can be caused by pelvic organ prolapse, neurological conditions, or habitual voiding patterns.

Hormonal and Life-Stage Factors

• Menopause and declining estrogen -- Estrogen supports the growth of protective Lactobacillus bacteria in the vagina and maintains the integrity of urethral and vaginal tissue. As estrogen levels decline after menopause, the vaginal pH rises, Lactobacillus populations decrease, and the urogenital tissue thins, all of which increase susceptibility to UTIs. Postmenopausal women have significantly higher rates of recurrent UTI.
• Pregnancy -- Hormonal and anatomical changes during pregnancy, including ureteral dilation and reduced bladder tone, increase the risk of UTI. Asymptomatic bacteriuria in pregnancy requires treatment due to the risk of pyelonephritis and adverse obstetric outcomes.

Behavioural and Lifestyle Factors

• Sexual activity -- Sexual intercourse is one of the strongest risk factors for UTI in premenopausal women. Mechanical pressure during intercourse can introduce bacteria into the urethra. Studies show that women who are sexually active are significantly more likely to develop UTIs than those who are not.
• Spermicide and diaphragm use -- Spermicides (including those on spermicide-coated condoms) disrupt normal vaginal flora, reducing protective Lactobacillus populations. Diaphragms can cause mechanical compression of the urethra, impairing bladder emptying.
• Wiping habits -- Wiping from back to front after using the toilet can transfer fecal bacteria toward the urethra.
• Use of irritating products -- Scented soaps, douches, bubble baths, and feminine hygiene sprays can irritate the urethra and disrupt the normal vaginal microbiome.

Medical Factors

• Diabetes -- Elevated blood glucose impairs immune function and promotes bacterial growth. Glycosuria (sugar in the urine) provides an ideal culture medium for bacteria.
• Immunosuppression -- Conditions or medications that weaken the immune system increase susceptibility to all infections, including UTIs.
• Urinary catheterization -- Indwelling catheters bypass the body's natural defences and provide a direct route for bacteria to enter the bladder.
• Kidney stones or structural abnormalities -- These can cause urinary stasis and serve as a nidus for persistent infection.
• History of UTI -- A prior UTI is itself one of the strongest predictors of future UTIs, likely due to a combination of genetic susceptibility, persistent bacterial reservoirs, and recurrent exposure to risk factors.

Diagnosing Recurrent UTIs

When recurrent UTIs are suspected, your healthcare provider will typically:

1. Take a thorough history -- including the timing, frequency, and severity of past infections, antibiotic use, sexual activity, contraceptive methods, and menopausal status.
2. Perform a urinalysis -- a dipstick test can quickly detect nitrites, leukocyte esterase, and blood, which suggest infection.
3. Order a urine culture and sensitivity -- this identifies the specific organism causing the infection and determines which antibiotics it is susceptible to. This step is particularly important in recurrent UTIs to guide targeted therapy and detect resistant organisms.
4. Consider imaging or cystoscopy -- in selected cases (such as when relapse is suspected, or when symptoms are atypical), ultrasound, CT scan, or cystoscopy may be performed to rule out structural abnormalities, stones, or other pathology.

In Canada, urine culture is typically covered under provincial health insurance plans when ordered by a physician or nurse practitioner. Patients should be aware that a mid-stream clean-catch urine specimen is necessary for accurate results.

Prevention Strategies

Preventing recurrent UTIs often requires a multi-pronged approach that combines behavioural changes, dietary modifications, and sometimes medical prophylaxis. The following strategies are supported by varying levels of clinical evidence.

Behavioural and Hygiene Measures

• Stay well-hydrated -- Drinking adequate water (at least 1.5 to 2 litres per day) increases urine output, which helps flush bacteria from the urinary tract. A randomized controlled trial published in JAMA Internal Medicine (2018) found that women who increased their daily water intake by 1.5 litres had 48% fewer UTI episodes compared to those who did not.
• Urinate frequently and do not delay voiding -- Regular emptying of the bladder prevents bacterial accumulation.
• Urinate after sexual intercourse -- While the evidence for this practice is observational rather than from randomized trials, it is a widely recommended, low-risk measure that may help flush bacteria introduced during intercourse.
• Wipe from front to back -- This simple habit reduces the chance of transferring intestinal bacteria to the urethra.
• Avoid scented products near the genital area -- Unscented soaps and water are sufficient for external genital hygiene. Douching should be avoided entirely, as it disrupts the protective vaginal microbiome.
• Wear breathable, cotton underwear -- Avoid tight-fitting synthetic clothing that traps moisture and creates an environment conducive to bacterial growth.
• Review contraceptive methods -- If you use spermicides or a diaphragm and experience recurrent UTIs, discuss alternative contraceptive options with your healthcare provider.

Dietary and Supplement Approaches

• Cranberry products -- Cranberries contain proanthocyanidins (PACs), compounds that may prevent E. coli from adhering to the bladder wall. A 2023 Cochrane review of over 50 trials found that cranberry products reduced the risk of UTI by approximately 25% in women with recurrent infections, with the strongest evidence for cranberry capsules or tablets standardized to PAC content. Cranberry juice cocktails with high sugar content are less effective and not generally recommended. Look for products containing at least 36 mg of PACs per day.
• D-mannose -- This naturally occurring sugar was once thought to interfere with E. coli adhesion to the bladder lining. However, a large randomized controlled trial published in JAMA (2024, n=598) found no significant difference in UTI recurrence between D-mannose and placebo (51.0% vs 55.7%). While D-mannose is available over the counter in Canada and is generally well tolerated, current evidence does not support its use as an effective preventive measure for recurrent UTIs.
• Probiotics -- Lactobacillus-based probiotics (particularly L. rhamnosus and L. reuteri) may help restore a healthy vaginal microbiome and compete with uropathogenic bacteria. Evidence is mixed but promising, and probiotics are considered safe for most people. Vaginal probiotic suppositories may be more effective than oral formulations for UTI prevention.
• Limit bladder irritants -- Caffeine, alcohol, artificial sweeteners, and highly acidic foods can irritate the bladder lining and may worsen UTI symptoms, though they do not directly cause infection.

Medical Prophylaxis

When behavioural measures and supplements are insufficient, your healthcare provider may recommend one of the following evidence-based prophylactic strategies:

• Vaginal estrogen therapy -- For peri- and postmenopausal women, topical vaginal estrogen (cream, ring, or tablet) is one of the most effective interventions for preventing recurrent UTI. The 2025 AUA/CUA/SUFU guideline strongly recommends vaginal estrogen for this population. By restoring vaginal Lactobacillus populations and normalizing vaginal pH, estrogen therapy has been shown to reduce UTI recurrence by approximately 58% in meta-analyses. Vaginal estrogen has minimal systemic absorption and is generally considered safe even in women for whom systemic hormone therapy is contraindicated.
• Low-dose antibiotic prophylaxis -- Continuous low-dose antibiotics taken daily or three times weekly for 6 to 12 months can reduce UTI recurrence by 60 to 95%. Common regimens include nitrofurantoin 50 mg nightly (50 mg is generally preferred over 100 mg, as studies show equivalent efficacy with fewer side effects), trimethoprim-sulfamethoxazole (TMP-SMX) half a single-strength tablet nightly, or fosfomycin 3 g every 10 days. Prophylaxis is typically reserved for women who have not responded to non-antibiotic strategies, due to concerns about antibiotic resistance, side effects, and disruption of normal flora.
• Post-coital antibiotic prophylaxis -- For women whose UTIs are clearly related to sexual activity, taking a single dose of antibiotic (such as nitrofurantoin 50-100 mg or TMP-SMX single strength) within two hours after intercourse can be highly effective while using less total antibiotic than continuous prophylaxis.
• Methenamine hippurate -- This urinary antiseptic converts to formaldehyde in acidic urine, killing bacteria without promoting antibiotic resistance. A large UK randomized trial (ALTAR, 2022) found that methenamine hippurate (1 g twice daily) was non-inferior to low-dose antibiotics for preventing recurrent UTI. It is an attractive option for women who wish to avoid antibiotic prophylaxis. Methenamine is available in Canada and is generally well tolerated.

Treatment of Acute UTI Episodes

When a recurrent UTI does occur, prompt treatment with appropriate antibiotics is essential to relieve symptoms and prevent complications.

First-Line Antibiotics in Canada

Canadian guidelines for uncomplicated lower UTI (acute cystitis) in adult women recommend the following first-line agents:

• Nitrofurantoin (Macrobid) -- 100 mg twice daily for 5 days. Nitrofurantoin achieves high concentrations in the urine and has maintained low resistance rates over decades. It should be avoided in patients with significant renal impairment (eGFR below 30 mL/min).
• Trimethoprim-sulfamethoxazole (TMP-SMX, Septra) -- one double-strength tablet (160/800 mg) twice daily for 3 days. TMP-SMX is effective and well-studied, but resistance rates are rising in some regions. It should be used empirically only when local resistance rates are below 20%.
• Fosfomycin (Monurol) -- a single 3 g oral dose. Fosfomycin is convenient due to its single-dose regimen, though it may be slightly less effective than multi-day therapies for some patients. It retains good activity against most uropathogenic E. coli, including many multidrug-resistant strains.

Second-Line and Alternative Agents

• Pivmecillinam (Selexid) -- 200 mg three times daily for 3 to 7 days (or 400 mg twice daily for 3 to 7 days as an alternative regimen). Pivmecillinam is widely used in Scandinavian countries and is available in Canada as Selexid (200 mg tablets). It has good activity against gram-negative uropathogens and low resistance rates.
• Fluoroquinolones (ciprofloxacin, levofloxacin) -- These are reserved for complicated UTIs or when first-line agents are unsuitable, due to serious adverse effects (tendon rupture, peripheral neuropathy, aortic dissection) and rising resistance. Health Canada has issued safety warnings regarding fluoroquinolone use.
• Beta-lactams (amoxicillin-clavulanate, cephalosporins) -- These may be used as alternatives when first-line agents are contraindicated, though they are generally less effective for uncomplicated UTI and may have a greater impact on normal gut flora.

For recurrent UTIs specifically, having urine culture results to guide antibiotic selection is particularly valuable. Your provider can tailor treatment to the specific organism and its susceptibility pattern, improving cure rates and reducing unnecessary broad-spectrum antibiotic use.

Self-Start (Patient-Initiated) Therapy

For selected patients with well-established patterns of recurrent UTI, healthcare providers may prescribe a course of antibiotics to have on hand at home. The patient can initiate treatment at the first sign of symptoms, collect a urine sample for culture confirmation, and contact their provider if symptoms do not improve within 48 hours. This approach reduces delays in treatment and unnecessary clinic visits, while still maintaining appropriate medical oversight.

When to See a Doctor

While mild UTI symptoms may be familiar territory for women with recurrent infections, certain situations warrant prompt medical evaluation:

• Fever above 38.0 degrees Celsius, chills, or flank pain -- These symptoms suggest a kidney infection (pyelonephritis), which requires more aggressive treatment and may need intravenous antibiotics.
• Blood in the urine (especially if visible or persistent) -- While small amounts of blood are common with cystitis, significant or recurrent hematuria should be investigated further.
• Symptoms that do not improve within 48 hours of starting antibiotics -- This may indicate antibiotic resistance or an alternative diagnosis.
• UTI symptoms during pregnancy -- UTIs in pregnancy carry risks for both mother and baby and should always be treated promptly.
• Recurrent infections (two or more in six months) -- A systematic evaluation and preventive strategy should be developed with your healthcare provider.
• UTI symptoms in men, children, or individuals with urinary tract abnormalities -- These are considered complicated UTIs and require further investigation.

Emerging Research and Future Directions

Several promising approaches to recurrent UTI prevention and treatment are currently under investigation:

• Vaccines -- MV140 (Uromune) is a sublingual bacterial vaccine that exposes the immune system to heat-inactivated uropathogenic bacteria. A 9-year follow-up presented at EAU 2024 found that 54% of participants remained UTI-free. MV140 is approved in approximately 20 countries. In Canada, the formal Health Canada regulatory submission was cancelled before a final decision, but MV140 is accessible through a Special Access Program. Other vaccine candidates targeting E. coli surface proteins are also in clinical trials.
• Bacteriophage therapy -- Phages are viruses that specifically target and destroy bacteria. Phage therapy offers the potential for highly targeted treatment without the collateral damage to normal flora seen with antibiotics. Early-phase clinical trials are underway for urinary tract infections.
• Fecal microbiota transplantation (FMT) -- Researchers are exploring whether restoring healthy gut flora through FMT might reduce colonization with uropathogenic E. coli strains, thereby preventing UTIs. This research is still in its early stages.
• Immunomodulatory agents -- OM-89 (Uro-Vaxom) is an oral immunostimulant containing E. coli extracts. It is used in some European and Asian countries for UTI prevention and has shown modest benefit in several clinical trials. It is not currently widely available in Canada but is an area of active interest.
• Intravesical therapies -- Bladder instillations with hyaluronic acid and chondroitin sulfate aim to repair the glycosaminoglycan (GAG) layer of the bladder lining, which serves as a barrier against bacterial adhesion. Some studies have shown promising reductions in UTI recurrence, particularly in postmenopausal women.

Frequently Asked Questions

1. How many UTIs per year is considered "recurrent"?
   Answer: Recurrent UTIs are generally defined as two or more infections within six months, or three or more within a twelve-month period. If you are experiencing infections at this frequency, you should discuss a prevention plan with your healthcare provider.
2. Can recurrent UTIs cause permanent kidney damage?
   Answer: Uncomplicated lower UTIs (cystitis) do not typically cause kidney damage. However, repeated kidney infections (pyelonephritis) that go untreated or are inadequately treated can potentially lead to scarring and impaired kidney function over time. This is why prompt and complete treatment of all UTIs is important.
3. Are UTIs sexually transmitted?
   Answer: UTIs are not considered sexually transmitted infections. However, sexual activity is a significant risk factor for UTIs because intercourse can introduce bacteria into the urethra. Urinating after intercourse and staying well-hydrated may help reduce this risk.
4. Can men get recurrent UTIs?
   Answer: Yes, though UTIs are less common in men due to their longer urethra. When men do experience recurrent UTIs, it often suggests an underlying condition such as an enlarged prostate, kidney stones, or a structural abnormality, and warrants thorough investigation.
5. Does cranberry juice really prevent UTIs?
   Answer: Cranberry products contain proanthocyanidins that may prevent bacteria from adhering to the bladder wall. A 2023 Cochrane review found modest benefit, particularly with cranberry capsules or tablets. However, sweetened cranberry juice cocktails are not recommended due to high sugar content and lower PAC concentration. If you choose to use cranberry, look for standardized supplements containing at least 36 mg of PACs daily.
6. Is it safe to take low-dose antibiotics for months to prevent UTIs?
   Answer: Long-term low-dose antibiotic prophylaxis (typically 6 to 12 months) is a well-established strategy for women with frequent recurrences and is generally safe. However, it does carry risks including yeast infections, gastrointestinal side effects, and the development of antibiotic-resistant bacteria. Non-antibiotic alternatives such as methenamine hippurate and vaginal estrogen (for postmenopausal women) should be considered first.
7. Can UTIs be diagnosed and treated through telemedicine?
   Answer: Yes. For straightforward, uncomplicated recurrent UTIs in women with a well-established pattern, telemedicine consultations can be an efficient way to obtain assessment and treatment. Your provider may request a urine culture to confirm the diagnosis and guide antibiotic selection.
8. Why do my UTIs keep coming back even after I finish antibiotics?
   Answer: There are several possible reasons. The original bacteria may have formed intracellular reservoirs in the bladder lining that are not fully cleared by antibiotics. You may also be experiencing reinfection with new bacteria due to ongoing risk factors. In some cases, the antibiotic prescribed may not have been effective against the specific organism. Urine culture with sensitivity testing can help identify the right antibiotic, and a comprehensive prevention plan can address modifiable risk factors.

How TeleTest Can Help

If you are dealing with recurrent UTIs, you do not have to wait weeks for a clinic appointment to get help. TeleTest offers convenient, confidential consultations with licensed Canadian physicians who can assess your symptoms, order urine cultures, prescribe appropriate antibiotics, and develop a personalized prevention plan -- all through secure online messaging.

Whether you need treatment for an acute UTI episode or want to discuss long-term prevention strategies, our clinicians are here to help. Start your consultation today and take control of your urinary health.

Disclaimer: This blog post is intended for educational purposes only and should not be taken as medical advice. Always consult your healthcare provider for personal health concerns.

---